MEI Pharma Becomes First US Public Firm to Hold Litecoin as Reserve Asset
MEI Pharma buys 929,548 LTC worth $110M, making it the first US public company with a Litecoin reserve and boosting optimism for an LTC ETF approval.
MEI Pharma buys 929,548 LTC worth $110M, making it the first US public company with a Litecoin reserve and boosting optimism for an LTC ETF approval.
